|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bipolar Disorder | |||||
| Alcohol Dependence | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Alcoholism | |||||
| Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Affective Disorders, Psychotic | |||||
| Alcohol-Related Disorders | |||||
| Disorders of Environmental Origin | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| Pathologic Processes | |||||
| Substance-Related Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Quetiapine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antipsychotic Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Texas Southwestern Medical Center | |||||